Anticarcinogenic composition comprising an inhibitor of DRG2 as an active ingredient

摘要

The present invention relates to an anticancer composition comprising a DRG2 inhibitor as an active ingredient, an inhibitor of expression of a DRG2 (Developmentally regulated GTP-binding protein 2) gene according to the present invention or an inhibitor of activity of a DRG2 protein inhibits cell migration, Since it can effectively inhibit the metastasis of cancer cells by a mechanism that inhibits Rac 1 activity and inhibits VE-cadherin protein expression, an inhibitor of expression of the developmentally regulated GTP-binding protein 2 (DRG2) gene or an inhibitor of activity of the DRG2 protein It will be useful as an anti-cancer composition that can block the metastasis of cancer.